Recombinant human CD40 ligand inhibits simian immunodeficiency virus replication: a role for interleukin- 16

M E Lee1, S Z Bucur, T W Gillespie

  • 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Insights

Recombinant human CD40 ligand (huCD40L) inhibits simian immunodeficiency virus (SIV) replication in vitro. This antiviral effect involves increased interleukin-16 (IL-16) mRNA expression and reduced viral antigen production.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • CD40 ligand (CD40L) on T cells interacts with CD40 on immune cells.
  • HIV infection diminishes CD4+ T cell CD40L expression.
  • An in vitro model using rhesus macaques with simian immunodeficiency virus (SIV) was employed.

Purpose of the Study:

  • To investigate the effect of recombinant human CD40L (huCD40L) on SIV replication in an in vitro model.
  • To explore the mechanisms underlying huCD40L's antiviral activity.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from SIV-infected rhesus macaques were cultured with huCD40L.
  • Viral p27 antigen production was measured.
  • Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to analyze SIV gag and IL-16 mRNA expression.

Main Results:

  • huCD40L induced PBMC proliferation independently of cytokines.
  • A 70% reduction in p27 production by SIV-infected PBMCs was observed (P < 0.05).
  • RT-PCR revealed decreased SIV gag mRNA and increased IL-16 mRNA expression.

Conclusions:

  • huCD40L inhibits SIVmac239 replication, including antigen and mRNA production.
  • The antiviral effect appears to be mediated by huCD40L-induced IL-16 mRNA expression.
  • This response is independent of beta-chemokines.